Article
Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors
4 May 2017
Abstract excerpt
BACKGROUND: Most patients with early stage triple negative breast cancer (TNBC) receive adjuvant chemotherapy. Activation of the immune system is associated with tumor response and may help identify TNBC with favorable outcome. METHODS: Gene expression data were obtained from the GEO Dataset GDS2250/GSE3744. Affymetrix CEL files were downloaded and analyzed with Affymetrix Transcriptome Analysis Console 3.0....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
